IHI and the Daisy Foundation™ Honor Nurses’ Commitment to Patient Safety

Nurses from Audie L. Murphy Memorial Veterans’ Hospital and UF Health Shands Hospital will receive awards at the IHI Patient Safety Congress 2023 BOSTON–(BUSINESS WIRE)–#IHICongress–The Institute for Healthcare Improvement (IHI) and the DAISY Foundation today announced the recipients of the 2023 DAISY Award® for Extraordinary Nurses in Patient Safety. The Hemodialysis Team at Audie L. … [Read more…]

SOPHiA GENETICS Celebrates Swiss Biotech Award

Recognition by the Swiss Biotech Association for SOPHiA GENETICS’ Outstanding Contributions as a Leader in Data-Driven Medicine BOSTON & LAUSANNE, Switzerland–(BUSINESS WIRE)–SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, was honored to accept the Swiss Biotech Success Stories Award from the Swiss Biotech Association. The … [Read more…]

FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients

The study, from the Tisch MS Research Center of New York, is the first to link stem cells with a broad array of improvements in multiple areas Progressive MS patients demonstrated better outcomes in walking speeds, gray matter volume, bladder function, and biomarker indicators NEW YORK–(BUSINESS WIRE)–The Tisch MS Research Center of New York, the … [Read more…]

Biocontrol Industry Leader Ashish Malik Partners with DunhamTrimmer Bio Intelligence as Senior Industry Associate

LAKEWOOD RANCH, Fla.–(BUSINESS WIRE)–DunhamTrimmer, the market leader in business intelligence for the biocontrol, biostimulant, biofertilizer, and specialty nutrition industries, announced today that Ashish Malik will be partnering with the company as Senior Industry Associate. A well-known leader in the biologicals market, Malik brings more than 20 years of experience in senior executive roles with agricultural … [Read more…]

Enanta Pharmaceuticals Announces Sale of a Portion of Global Royalties on MAVYRET® (U.S.)/MAVIRET® (ex-U.S.) (Glecaprevir/Pibrentasvir) to OMERS Life Sciences for $200 Million

Non-Dilutive and Strengthens Balance Sheet Competitive Process Results in the Sale of 54.5% of the MAVYRET®/MAVIRET® Royalty Interest, Subject to a 1.42x Cap Sale Proceeds to Fund Continuing Clinical Development Across Virology Pipeline WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced … [Read more…]

Vertex to Present at the Bank of America Securities 2023 Health Care Conference on May 9

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the Bank of America Securities 2023 Health Care Conference on Tuesday, May 9, 2023 at 9:20 a.m. PT/12:20 p.m. ET. A live webcast of management’s remarks will be available through the Vertex website, www.vrtx.com in the “Investors” section under the “News and … [Read more…]

UroGen Pharma to Present at H.C. Wainwright BioConnect Conference

– Fireside Chat May 2, 2023 from 10:00 – 10:30 AM ET – PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in a fireside chat at the upcoming H.C. Wainwright BioConnect Conference on May … [Read more…]

Corner Therapeutics Appoints Rick Malley, M.D., to Serve on Scientific Advisory Board

WATERTOWN, Mass.–(BUSINESS WIRE)–Corner Therapeutics, a biotechnology company exploiting a new scientific paradigm to boost the intelligence of the natural immune response to disease, today announced the appointment of Rick Malley, M.D., to their Scientific Advisory Board. Malley is experienced in pediatric infectious disease, with his prior work focused on developing novel vaccine platforms and pneumococcal … [Read more…]

VBI Vaccines Appoints Vaughn Himes to Board of Directors

CAMBRIDGE, Mass.–(BUSINESS WIRE)–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Vaughn B. Himes, Ph.D., Chief Technical Officer of Seagen Inc., has joined VBI’s Board of Directors. Dr. Himes has a 30+-year successful track record in biotechnology strategic direction … [Read more…]

BeiGene Announces Goals Focused on Sustainable Growth and Workforce Diversity in New ESG Report

Newly Released Report Details Company’s Progress and Plans for Growing Responsibly BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, announced several new Environmental, Social, and Governance (ESG) goals today, including targets related to carbon emissions and workforce diversity. These goals are outlined in the … [Read more…]